CIK 0001712762 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
bioAffinity Technologies, Inc.
Sign in to watch- Ticker
- BIAF
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465211056
- Phone
- 210-698-5334
- Business address
- 3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
- Former names
- bioAffinity Technologies, Inc.
Securities
- BIAF Common Stock Nasdaq
- BIAFW Warrant Nasdaq
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change · Regulation FD disclosure
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Results of operations · Other events
- 4 Grant or award Director acquired 33,784 shares (grant or award)
- 4 Grant or award Executive Chairman acquired 33,784 shares (grant or award)
- 4 Grant or award Director acquired 33,784 shares (grant or award)
- 4 Grant or award Director acquired 33,784 shares (grant or award)
- 4 Grant or award President & CEO acquired 33,784 shares (grant or award)
- 4 Grant or award Director acquired 33,784 shares (grant or award)
Page 11 of 21 · 401 filings